Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Med ; 6(11): 2507-2514, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28960797

ABSTRACT

Several studies have reported uneven results when evaluating the prognostic value of bone marrow biopsy (BMB) and PET/CT as part of the staging of diffuse large B-cell lymphoma (DLBCL). The heterogeneity of the inclusion criteria and not taking into account selection and collinearity biases in the analysis models might explain part of these discrepancies. To address this issue we have carried a retrospective multicenter study including 268 DLBCL patients with a BMB and a PET/CT available at diagnosis where we estimated both the prognosis impact and the diagnostic accuracy of each technique. Only patients treated with R-CHOP/21 as first line (n = 203) were included in the survival analysis. With a median follow-up of 25 months the estimated 3-year progression-free survival (PFS) and overall survival (OS) were 76.3% and 82.7% respectively. In a multivariate analysis designed to avoid a collinearity bias with IPI categories, BMB-BMI [bone marrow involvement](+) (HR: 3.6) and ECOG PS > 1 (HR: 2.9) were independently associated with a shorter PFS and three factors, age >60 years old (HR: 2.4), ECOG PS >1 (HR: 2.4), and abnormally elevated B2-microglobulin levels (HR: 2.2) were independently associated with a shorter OS. In our DLBCL cohort, treated with a uniform first-line chemotherapy regimen, BMI by BMB complemented performance status in predicting those patients with a higher risk for relapse or progression. In this cohort BMI by PET/CT could not independently predict a shorter PFS and/or OS.


Subject(s)
Bone Marrow/diagnostic imaging , Bone Marrow/pathology , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse/pathology , Positron Emission Tomography Computed Tomography , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Cyclophosphamide/therapeutic use , Disease-Free Survival , Doxorubicin/therapeutic use , Female , Follow-Up Studies , Health Status , Humans , Lymphoma, Large B-Cell, Diffuse/drug therapy , Male , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Prednisone/therapeutic use , Retrospective Studies , Rituximab/administration & dosage , Survival Rate , Vincristine/therapeutic use , Young Adult , beta 2-Microglobulin/blood
2.
Pest Manag Sci ; 73(5): 1017-1023, 2017 May.
Article in English | MEDLINE | ID: mdl-27558547

ABSTRACT

BACKGROUND: Developments of alternatives to the use of chemical pesticides to control pests are focused on the induction of natural plant defences. The study of new compounds based on liquid bioassimilable sulphur and its effect as an inductor of the immune system of plants would provide an alternative option to farmers to enhance plant resistance against pathogen attacks such as powdery mildew. In order to elucidate the efficacy of this compound in tomato against powdery mildew, we tested several treatments: curative foliar, preventive foliar, preventive in soil drench and combining preventive in soil drench and curative foliar. RESULTS: In all cases, treated plants showed lower infection development, better physiological parameters and a higher level of chlorophyll. We also observed better performance in parameters involved in plant resistance such as antioxidant response, callose deposition and hormonal levels. CONCLUSION: The results indicate that preventive and curative treatments can be highly effective for the prevention and control of powdery mildew in tomato plants. Foliar treatments are able to stop the pathogen development when they are applied as curative. Soil drench treatments induce immune response mechanisms of plants, increasing significantly callose deposition and promoting plant development. © 2016 Society of Chemical Industry.


Subject(s)
Ascomycota/drug effects , Ascomycota/physiology , Solanum lycopersicum/drug effects , Solanum lycopersicum/immunology , Sulfur/metabolism , Sulfur/pharmacology , Chlorophyll/metabolism , Glucans/metabolism , Hydrogen Peroxide/metabolism , Solanum lycopersicum/metabolism , Solanum lycopersicum/microbiology , Plant Diseases/immunology , Plant Diseases/microbiology , Plant Growth Regulators/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...